Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Changing trends in phthalate exposures: Zota and Woodruff respond.

Zota AR, Woodruff TJ

Environ Health Perspect 2014 Oct doi: 10.1289/ehp.1408629R

The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth.

Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, Robinson KA, Axelrad DA, Woodruff TJ

Environ Health Perspect 2014 Oct doi: 10.1289/ehp.1307893

Social integration and mortality in patients with coronary heart disease: findings from the Heart and Soul Study.

Kreibig SD, Whooley MA, Gross JJ

Psychosom Med 2014 Oct doi: 10.1097/PSY.0000000000000100

Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy.

Maquilan G, Grover S, Alonso-Basanta M, Lustig RA

Am J Clin Oncol 2014 Oct doi: 10.1097/COC.0b013e31827de86b

Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, Unger ER

Am J Obstet Gynecol 2014 Oct doi: 10.1016/j.ajog.2014.05.001

Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population.

He SY, McCulloch CE, Boscardin WJ, Chren MM, Linos E, Arron ST

J Am Acad Dermatol 2014 Oct doi: 10.1016/j.jaad.2014.05.023

A variation in the value of colectomy for cancer across hospitals: mortality, readmissions, and costs.

Fox JP, Tyler JA, Vashi AA, Hsia RY, Saxe JM

Surgery 2014 Oct doi: 10.1016/j.surg.2014.06.011

Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation.

Yazdany J, Marafino BJ, Dean ML, Bardach NS, Duseja R, Ward MM, Dudley RA

Arthritis Rheumatol 2014 Oct doi: 10.1002/art.38768

Fighting the "oculostenotic reflex".

Lin GA, Dudley RA

JAMA Intern Med 2014 Oct doi: 10.1001/jamainternmed.2014.164

Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

Egloff AM, Lee JW, Langer CJ, Quon H, Vaezi A, Grandis JR, Seethala RR, Wang L, Shin DM, Argiris A, Yang D, Mehra R, Ridge JA, Patel UA, Burtness BA, Forastiere AA

Clin Cancer Res 2014 Oct doi: 10.1158/1078-0432.CCR-14-0051